<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38954717</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>7</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Clinical characteristics and factors associated with long COVID among post-acute COVID-19 clinic patients in Zambia, August 2020 to January 2023: A cross-sectional and longitudinal study design.</ArticleTitle><Pagination><StartPage>e0306131</StartPage><MedlinePgn>e0306131</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0306131</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0306131</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">A number of seroprevalence studies in Zambia document the extent of spread of acute SARS-CoV-2 infection, yet knowledge gaps still exist on symptoms and conditions that continue or develop after acute COVID-19 (long COVID). This is an important gap given the estimated prevalence of long COVID in other African countries. We assessed factors associated with long COVID at the initial visit to a post-acute COVID-19 (PAC-19) clinic and longitudinally among a cohort of patients with &#x2265;2 review visits.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We implemented a cross-sectional and longitudinal analysis of PAC-19 clinic patients from Aug-2020 to Jan-2023. The study outcome was long COVID; defined as the presence of new, relapsing, or persistent COVID-19 symptoms that interfere with the ability to function at home or work. Explanatory variables were demographic and clinical characteristics of patients which included sex, age group, presence of new onset medical conditions, presence of pre-existing comorbidities, vaccination status and acute COVID-19 episode details. We fitted logistic and mixed effects regression models to assess for associated factors and considered statistical significance at p&lt;0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of a total 1,359 PAC-19 clinic patients in the cross-sectional analysis, 548 (40.3%) patients with &#x2265;2 PAC-19 clinic visits were in the longitudinal analysis. Patients' median age was 53 (interquartile range [IQR]: 41-63) years, 919 (67.6%) were hospitalized for acute COVID-19, and of whom 686 (74.6%) had severe acute COVID-19. Overall, 377 (27.7%) PAC-19 clinic patients had long COVID. Patients with hospital length of stay &#x2265;15 days (adjusted odds ratio [aOR]: 5.37; 95% confidence interval [95% CI]: 2.99-10.0), severe acute COVID-19 (aOR: 3.22; 95% CI: 1.68-6.73), and comorbidities (aOR:1.50; 95% CI: 1.02-2.21) had significantly higher chance of long COVID. Longitudinally, long COVID prevalence significantly (p&lt;0.001) declined from 75.4% at the initial PAC-19 visit to 26.0% by the final visit. The median follow-up time was 7 (IQR: 4-12) weeks.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Factors associated with long COVID in Zambia were consistent both cross-sectionally at the initial visit to PAC-19 clinics and longitudinally across subsequent review visits. This highlights the importance of ongoing monitoring and tailored interventions for patients with comorbidities and severe COVID-19 to mitigate the long-term impacts of COVID-19.</AbstractText><CopyrightInformation>Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malambo</LastName><ForeName>Warren</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-4811-9831</Identifier><AffiliationInfo><Affiliation>Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Global Health Center, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chanda</LastName><ForeName>Duncan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5477-9054</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University Teaching Hospital Adult and Emergency Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besa</LastName><ForeName>Lily</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engamba</LastName><ForeName>Daniella</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University Teaching Hospital Adult and Emergency Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mwiinga</LastName><ForeName>Linos</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Global Health Center, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mwitumwa</LastName><ForeName>Mundia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University Teaching Hospital Adult and Emergency Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matibula</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University Teaching Hospital Adult and Emergency Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naik</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University Teaching Hospital Adult and Emergency Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivile</LastName><ForeName>Suilanji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University Teaching Hospital Adult and Emergency Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agolory</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Global Health Center, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Auld</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Global Health Center, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulenga</LastName><ForeName>Lloyd</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hines</LastName><ForeName>Jonas Z</ForeName><Initials>JZ</Initials><Identifier Source="ORCID">0000-0002-4877-0333</Identifier><AffiliationInfo><Affiliation>Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Global Health Center, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fwoloshi</LastName><ForeName>Sombo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University Teaching Hospital Adult and Emergency Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015024" MajorTopicYN="N" Type="Geographic">Zambia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>21</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>21</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>14</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38954717</ArticleId><ArticleId IdType="pmc">PMC11219000</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0306131</ArticleId><ArticleId IdType="pii">PONE-D-23-42851</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. International Health Regulations Emergency Committee on novel coronavirus in China Geneva, Switzerland: 2020.  [Available from: https://www.who.int/news-room/events/detail/2020/01/30/default-calendar/international-health-regulations-emergency-committee-on-novel-coronavirus-in-china].</Citation></Reference><Reference><Citation>WHO. WHO Coronavirus (COVID-19) Dashboard: World Health Organization; 2023.  [Available from: https://covid19.who.int/].</Citation></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021;15(3):869&#x2013;75. doi: 10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al.. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. European Respiratory Journal. 2020;56(1):2001494. doi: 10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al.. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e7. doi: 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Benatti SV, Casati M, Binda F, Zuglian G, Imeri G, et al.. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiology and Infections. 2021;149:e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, et al.. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. Journal of Rehabil itation of Medicine. 2020;52(5):jrm00063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G, et al.. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5):401&#x2013;9. doi: 10.1136/thx.2004.030205</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.030205</ArticleId><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, Wing YK, Yu MW, Leung CM, Ma RC, Kong AP, et al.. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. JAMA Internal Medicine. 2009;169(22):2142&#x2013;7. doi: 10.1001/archinternmed.2009.384</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Shin HS, Park HY, Kim JL, Lee JJ, Lee H, et al.. Depression as a Mediator of Chronic Fatigue and Post-Traumatic Stress Symptoms in Middle East Respiratory Syndrome Survivors. Psychiatry Investigation. 2019;16(1):59&#x2013;64. doi: 10.30773/pi.2018.10.22.3</Citation><ArticleIdList><ArticleId IdType="doi">10.30773/pi.2018.10.22.3</ArticleId><ArticleId IdType="pmc">PMC6354037</ArticleId><ArticleId IdType="pubmed">30605995</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al.. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. Jama. 2023;329(22):1934&#x2013;46. doi: 10.1001/jama.2023.8823</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahey GM, Marshall KE, McDonald E, Martin SW, Tate JE, Midgley CM, et al.. Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020. Emerging infectious diseases. 2021;27(2):385&#x2013;95. doi: 10.3201/eid2702.203729</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2702.203729</ArticleId><ArticleId IdType="pmc">PMC7853576</ArticleId><ArticleId IdType="pubmed">33496225</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al.. Post-acute COVID-19 syndrome. Nature Medicine. 2021;27(4):601&#x2013;15. doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Chippa V, Aleem A, Anjum F. Post Acute Coronavirus (COVID-19) Syndrome: StatPearls Publishing, Treasure Island (FL); 2021 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34033370</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh V, Arroliga AC, Bourgeois JA, Boehm LM, McNeal MJ, Widmer AJ, et al.. Symptom Clusters Seen in Adult COVID-19 Recovery Clinic Care Seekers. J Gen Intern Med. 2023;38(2):442&#x2013;9. doi: 10.1007/s11606-022-07908-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07908-4</ArticleId><ArticleId IdType="pmc">PMC9663188</ArticleId><ArticleId IdType="pubmed">36376627</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Post COVID-19 condition (Long COVID) 2022 [Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition].</Citation></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. Jama. 2020;324(6):603&#x2013;5. doi: 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England). 2021;397(10270):220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al.. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March-June 2020. MMWR Morbidity and mortality weekly report. 2020;69(30):993&#x2013;8. doi: 10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet (London, England). 2022;400(10350):452&#x2013;61. doi: 10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, Pouwels KB, Glickman M, Nafilyan V, et al.. Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. Open Forum Infect Dis. 2022;9(9):ofac464. doi: 10.1093/ofid/ofac464</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, Boehmer TK, Adjei S, Gray S, Harris AM. Post&#x2013;COVID Conditions Among Adult COVID-19 Survivors Aged 18&#x2013;64 and &#x2265;65 Years&#x2014;United States, March 2020&#x2013;November 2021. MMWR Morbidity and mortality weekly report. 2022;71(21):713&#x2013;7.</Citation></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al.. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28(11):2406&#x2013;15. doi: 10.1038/s41591-022-02001-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology. 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyasulu PS, Tamuzi JL, Erasmus RT. Burden, causation, and particularities of Long COVID in African populations: A rapid systematic review. IJID Regions. 2023;8:137&#x2013;44. doi: 10.1016/j.ijregi.2023.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijregi.2023.08.004</ArticleId><ArticleId IdType="pmc">PMC10477483</ArticleId><ArticleId IdType="pubmed">37674565</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al.. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R, Mariani F, Mastrantoni L, De Rose C, Zampino G, Munblit D, et al.. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study. eClinicalMedicine. 2023;59:101961. doi: 10.1016/j.eclinm.2023.101961</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101961</ArticleId><ArticleId IdType="pmc">PMC10101848</ArticleId><ArticleId IdType="pubmed">37073325</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al.. Risk Factors Associated With Post&#x2212;COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Internal Medicine. 2023;183(6):566&#x2013;80. doi: 10.1001/jamainternmed.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Frallonardo L, Segala FV, Chhaganlal KD, Yelshazly M, Novara R, Cotugno S, et al.. Incidence and burden of long COVID in Africa: a systematic review and meta-analysis. Scientific Reports. 2023;13(1):21482. doi: 10.1038/s41598-023-48258-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-48258-3</ArticleId><ArticleId IdType="pmc">PMC10700349</ArticleId><ArticleId IdType="pubmed">38057338</ArticleId></ArticleIdList></Reference><Reference><Citation>Osikomaiya B, Erinoso O, Wright KO, Odusola AO, Thomas B, Adeyemi O, et al.. &#x2018;Long COVID&#x2019;: persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infectious Diseases. 2021;21(1):304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993075</ArticleId><ArticleId IdType="pubmed">33765941</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller SA, Isaaka L, Mumm R, Scheidt-Nave C, Heldt K, Schuster A, et al.. Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review. Lancet Glob Health. 2023;11(11):e1713&#x2013;e24. doi: 10.1016/S2214-109X(23)00384-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(23)00384-4</ArticleId><ArticleId IdType="pubmed">37858583</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden M, Mudara C, Vika C, Blumberg L, Mayet N, Cohen C, et al.. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study. Lancet Glob Health. 2022;10(9):e1247&#x2013;e56. doi: 10.1016/S2214-109X(22)00286-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(22)00286-8</ArticleId><ArticleId IdType="pmc">PMC9363040</ArticleId><ArticleId IdType="pubmed">35961348</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyo E, Chimene M, Moyo P, Musuka G, Mangoya D, Murewanhema G, Dzinamarira T. Risk factors and clinical presentations of long COVID in Africa: A scoping review. Journal of Infection and Public Health. 2023;16(12):1982&#x2013;8. doi: 10.1016/j.jiph.2023.09.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.09.021</ArticleId><ArticleId IdType="pubmed">37890221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulu JE, Banda D, Hines JZ, Luchembe M, Sivile S, Siwingwa M, et al.. Two-month follow-up of persons with SARS-CoV-2 infection-Zambia, September 2020: a cohort study. The Pan African medical journal. 2022;41:26. doi: 10.11604/pamj.2022.41.26.30721</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2022.41.26.30721</ArticleId><ArticleId IdType="pmc">PMC8895565</ArticleId><ArticleId IdType="pubmed">35291364</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulenga LB, Hines JZ, Fwoloshi S, Chirwa L, Siwingwa M, Yingst S, et al.. Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey. Lancet Glob Health. 2021;9(6):e773&#x2013;e81. doi: 10.1016/S2214-109X(21)00053-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00053-X</ArticleId><ArticleId IdType="pmc">PMC8382844</ArticleId><ArticleId IdType="pubmed">33711262</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheppard RJ, Watson OJ, Pieciak R, Lungu J, Kwenda G, Moyo C, et al.. Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context. Nat Commun. 2023;14(1):3840. doi: 10.1038/s41467-023-39288-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39288-6</ArticleId><ArticleId IdType="pmc">PMC10307769</ArticleId><ArticleId IdType="pubmed">37380650</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill CJ, Mwananyanda L, MacLeod WB, Kwenda G, Pieciak RC, Etter L, et al.. What is the prevalence of COVID-19 detection by PCR among deceased individuals in Lusaka, Zambia? A postmortem surveillance study. BMJ Open. 2022;12(12):e066763. doi: 10.1136/bmjopen-2022-066763</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-066763</ArticleId><ArticleId IdType="pmc">PMC9729848</ArticleId><ArticleId IdType="pubmed">36600354</ArticleId></ArticleIdList></Reference><Reference><Citation>Heilmann E, Tembo T, Chilambe F, Fwoloshi S, Kalenga K, Siwingwa M, et al. SARS-COV-2 seroprevalence trend among pregnant women in Zambia, 2021&#x2013;2022. Conference on Retroviruses and Opportunistic Infections (CROI); February 19&#x2013;22, 2023; Seattle, Washington2023.</Citation></Reference><Reference><Citation>Mumba TK, Merwe KVD, Divall M, Mwangilwa K, Kayeyi N. Seroprevalence survey of SARS-CoV-2, community behaviors, and practices in Kansanshi and Kalumbila mining towns. Frontiers in Public Health. 2023;11. doi: 10.3389/fpubh.2023.1103133</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1103133</ArticleId><ArticleId IdType="pmc">PMC10548386</ArticleId><ArticleId IdType="pubmed">37799157</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanaube K, Schaap A, Klinkenberg E, Floyd S, Bwalya J, Cheeba M, et al.. SARS-CoV-2 seroprevalence and associated risk factors in periurban Zambia: a population-based study. Int J Infect Dis. 2022;118:256&#x2013;63. doi: 10.1016/j.ijid.2022.03.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.03.021</ArticleId><ArticleId IdType="pmc">PMC8925090</ArticleId><ArticleId IdType="pubmed">35306205</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis HC, Ware H, Whelan M, Subissi L, Li Z, Ma X, et al.. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. BMJ Glob Health. 2022;7(8). doi: 10.1136/bmjgh-2022-008793</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2022-008793</ArticleId><ArticleId IdType="pmc">PMC9402450</ArticleId><ArticleId IdType="pubmed">35998978</ArticleId></ArticleIdList></Reference><Reference><Citation>Mwangilwa K, Simwanza J, Shumba S, Gama A, Chipoya M, Sakubita P, et al.. Factors associated with time to recovery among COVID-19 patients in selected Zambian hospitals, 2020. Journal of Interventional Epidemiology and Public Health. 2024;7(4).</Citation></Reference><Reference><Citation>Ministry of Health (Zambia). Clinical Guidance for Management of Patients with Coronavirus Disease 2019 (COVID-19) Lusaka2020 [Available from: https://www.moh.gov.zm/?wpfb_dl=181].</Citation></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne). 2023;10:1187163. doi: 10.3389/fmed.2023.1187163</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>GISAID. EpiCov 2023 [Available from: https://www.epicov.org/epi3/frontend#24d000.</Citation></Reference><Reference><Citation>Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121&#x2013;6. doi: 10.4103/0253-7176.116232</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0253-7176.116232</ArticleId><ArticleId IdType="pmc">PMC3775042</ArticleId><ArticleId IdType="pubmed">24049221</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Pal D, Das K, G A, Venkateshan M, et al.. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19. PLoS One. 2022;17(12):e0278825. doi: 10.1371/journal.pone.0278825</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. European Journal of Internal Medicine. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Barrett KMS, Riffle S, Bolze A, Neveux I, Dabe S, et al.. Long-term COVID-19 symptoms in a large unselected population. medRxiv. 2020:2020.10.07.20208702.</Citation></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al.. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iran J Med Sci. 2021;46(6):428&#x2013;36. doi: 10.30476/ijms.2021.92080.2326</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong RSY. Inflammation in COVID-19: from pathogenesis to treatment. Int J Clin Exp Pathol. 2021;14(7):831&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339720</ArticleId><ArticleId IdType="pubmed">34367415</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HP, Sun YL, Wang YF, Yazici D, Azkur D, Ogulur I, et al.. Recent developments in the immunopathology of COVID-19. Allergy. 2023;78(2):369&#x2013;88. doi: 10.1111/all.15593</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15593</ArticleId><ArticleId IdType="pmc">PMC10108124</ArticleId><ArticleId IdType="pubmed">36420736</ArticleId></ArticleIdList></Reference><Reference><Citation>Rane MS, Robertson MM, Kulkarni SG, Frogel D, Gainus C, Nash D. Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting. Vaccine. 2023;41(4):989&#x2013;98. doi: 10.1016/j.vaccine.2022.12.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.12.039</ArticleId><ArticleId IdType="pmc">PMC9763212</ArticleId><ArticleId IdType="pubmed">36588007</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton A, Fleming-Dutra KE, Shang N, Smith ZR, Dorji T, Derado G, et al.. Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance. Jama. 2022;327(11):1032&#x2013;41. doi: 10.1001/jama.2022.2068</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.2068</ArticleId><ArticleId IdType="pmc">PMC8845038</ArticleId><ArticleId IdType="pubmed">35157002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanda D, Hines JZ, Itoh M, Fwoloshi S, Minchella PA, Zyambo KD, et al.. COVID-19 Vaccine Effectiveness Against Progression to In-Hospital Mortality in Zambia, 2021&#x2013;2022. Open Forum Infect Dis. 2022;9(9):ofac469. doi: 10.1093/ofid/ofac469</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac469</ArticleId><ArticleId IdType="pmc">PMC9522674</ArticleId><ArticleId IdType="pubmed">36196297</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>